These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1684188)

  • 21. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
    Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
    Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
    Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
    Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment].
    Mitrokhin SD
    Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel.
    Fernandez C; Gaspar C; Torrellas A; Vindel A; Saez-Nieto JA; Cruzet F; Aguilar L
    J Antimicrob Chemother; 1995 Mar; 35(3):399-408. PubMed ID: 7782256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness.
    Boelaert JR; De Baere YA; Geernaert MA; Godard CA; Van Landuyt HW
    J Hosp Infect; 1991 Sep; 19 Suppl B():41-6. PubMed ID: 1684192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery.
    Yano M; Doki Y; Inoue M; Tsujinaka T; Shiozaki H; Monden M
    Surg Today; 2000; 30(1):16-21. PubMed ID: 10648077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
    Wertheim HF; Vos MC
    Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
    Shrestha NK; Banbury MK; Weber M; Cwynar RE; Lober C; Procop GW; Karafa MT; Gordon SM
    Ann Thorac Surg; 2006 Jun; 81(6):2183-8. PubMed ID: 16731151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
    Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1986 Mar; 17(3):365-72. PubMed ID: 3084442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization.
    Simor AE; Phillips E; McGeer A; Konvalinka A; Loeb M; Devlin HR; Kiss A
    Clin Infect Dis; 2007 Jan; 44(2):178-85. PubMed ID: 17173213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of Staphylococcus aureus in hemodialysis patients.
    Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W
    ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results.
    Pérez-Fontán M; García-Falcón T; Rosales M; Rodríguez-Carmona A; Adeva M; Rodríguez-Lozano I; Moncalián J
    Am J Kidney Dis; 1993 Nov; 22(5):708-12. PubMed ID: 8238017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methicillin-Resistant Staphylococcus aureus in a Trauma Population: Does Decolonization Prevent Infection?
    Maxwell RA; Croft CA; Creech CB; Thomsen I; Soper N; Brown LE; Mejia VA; Dart BW; Barker DE
    Am Surg; 2017 Dec; 83(12):1407-1412. PubMed ID: 29336763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients.
    Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L
    Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment.
    Sloot N; Siebert J; Höffler U
    Zentralbl Hyg Umweltmed; 1999 Dec; 202(6):513-23. PubMed ID: 10631792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.
    Anderson MJ; David ML; Scholz M; Bull SJ; Morse D; Hulse-Stevens M; Peterson ML
    Antimicrob Agents Chemother; 2015 May; 59(5):2765-73. PubMed ID: 25733504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
    Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
    Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
    Fawley WN; Parnell P; Hall J; Wilcox MH
    J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The influence of the use of mupirocin nasal ointment on the incidence of endogenous MRSA infections in an intensive care unit].
    Hiramatsu N; Hashimoto S; Fujita N; Kageyama K; Ashida H; Kimura A; Kobayashi A; Tanaka Y
    Masui; 2000 Aug; 49(8):867-71. PubMed ID: 10998878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.